Владения компаниями для Cormorant Asset Management, LP

Компания Доля, %
Ambrx Biopharma Inc. 17.78
Chemomab Therapeutics Ltd. 15.66
Immuneering Corporation 14.36
Harpoon Therapeutics, Inc. 13.87
Biomea Fusion, Inc. 9.95
VYNE Therapeutics Inc. 9.89
Longboard Pharmaceuticals, Inc. 7
Tarsus Pharmaceuticals, Inc. 6.49
ALX Oncology Holdings Inc. 6.27
Praxis Precision Medicines, Inc. 4.78
Enliven Therapeutics, Inc. 4.71
Tango Therapeutics, Inc. 4.65
Olema Pharmaceuticals, Inc. 4.39
Aerovate Therapeutics, Inc. 4.35
VectivBio Holding AG 4.04
Alpine Immune Sciences, Inc. 3.89
Prometheus Biosciences, Inc. 3.46
Pharvaris B.V. 3.28
Arcellx, Inc. 3.22
BioAtla, Inc. 2.46
Talaris Therapeutics, Inc. 2.14
Autolus Therapeutics plc 2.05
BridgeBio Pharma, Inc. 1.9
GH Research PLC 1.14